Chemokine-like Receptor 1 (CMKLR1) and Chemokine (C-C Motif) Receptor-like 2 (CCRL2); Two Multifunctional Receptors with Unusual Properties
Overview
Authors
Affiliations
Chemokine-like receptor 1 (CMKLR1), also known as ChemR23, and chemokine (C-C motif) receptor-like 2 (CCRL2) are 7-transmembrane receptors that were cloned in the late 1990s based on their homology to known G-protein-coupled receptors. They were previously orphan receptors without any known biological roles; however, recent studies identified ligands for these receptors and their functions have begun to be unveiled. The plasma protein-derived chemoattractant chemerin is a ligand for CMKLR1 and activation of CMKLR1 with chemerin induces the migration of macrophages and dendritic cells (DCs) in vitro, suggesting a proinflammatory role. However, in vivo studies using CMKLR-deficient mice suggest an anti-inflammatory role for this receptor, possibly due to the recruitment of tolerogenic plasmacytoid DCs. Chemerin/CMKLR1 interaction also promotes adipogenesis and angiogenesis. The anti-inflammatory lipid mediator, resolving E1, is another CMKLR1 ligand and it inhibits leukocyte infiltration and proinflammatory gene expression. These divergent results suggest that CMKLR1 is a multifunctional receptor. The chemokine CCL5 and CCL19 are reported to bind to CCRL2. Like Duffy antigen for chemokine receptor (DARC), D6 and CCX-CKR, CCRL2 does not signal, but it constitutively recycles, potentially reducing local concentration of CCL5 and CCL19 and subsequent immune responses. Surprisingly, chemerin, a ligand for CMKLR1, is a ligand for CCRL2. CCRL2 binds chemerin and increases local chemerin concentration to efficiently present it to CMKLR1 on nearby cells, providing a link between CCRL2 and CMKLR1. Although these findings suggest an anti-inflammatory role, a recent study using CCRL2-deficient mice indicates a proinflammatory role; thus, CCRL2 may also be multifunctional. Further studies using CMKLR1- or CCRL2-deficient mice are needed to further define the role of these receptors in immune responses and other cellular processes.
Structural Basis for Chemerin Recognition and Signaling Through Its Receptors.
Liu Y, Liu A, Ye R Biomedicines. 2024; 12(11).
PMID: 39595036 PMC: 11592271. DOI: 10.3390/biomedicines12112470.
Ji J, Zhong H, Wang Y, Liu J, Tang J, Liu Z Cell Death Dis. 2024; 15(6):425.
PMID: 38890311 PMC: 11189533. DOI: 10.1038/s41419-024-06820-5.
Liu X, Wu S, Peng Y, Gao L, Huang X, Deng R Front Pharmacol. 2024; 15:1341854.
PMID: 38783935 PMC: 11111959. DOI: 10.3389/fphar.2024.1341854.
Unveiling heterogeneity in MSCs: exploring marker-based strategies for defining MSC subpopulations.
Chen S, Liang B, Xu J J Transl Med. 2024; 22(1):459.
PMID: 38750573 PMC: 11094970. DOI: 10.1186/s12967-024-05294-5.
Liu Z, Chen Y, Chen Y, Zheng J, Wu W, Wang L Int J Mol Sci. 2024; 25(8).
PMID: 38673909 PMC: 11049903. DOI: 10.3390/ijms25084324.